Preliminary studies indicate conolidine might inhibit distinct ion channels, lowering neuronal excitability and limiting agony signals. This system is especially related in neuropathic ache, wherever abnormal signaling leads to persistent soreness. In addition, conolidine seems to influence G protein-coupled receptor (GPCR) pathways integral to ago